Contrast-enhanced ultrasound for assessing abdominal conditions in pregnancy

Background and objectives: Native ultrasound is the most common imaging modality in obstetrics. The use of contrast-enhanced ultrasound (CEUS) during pregnancy has not been officially approved by leading societies for obstetrics and ultrasound. The present study aims to monitor the safety and diagno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Geyer, Thomas (VerfasserIn) , Rübenthaler, Johannes (VerfasserIn) , Froelich, Matthias F. (VerfasserIn) , Sabel, Laura (VerfasserIn) , Marschner, Constantin (VerfasserIn) , Schwarze, Vincent (VerfasserIn) , Clevert, Dirk-André (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 8 December 2020
In: Medicina
Year: 2020, Jahrgang: 56, Heft: 12, Pages: 1-12
ISSN:1648-9144
DOI:10.3390/medicina56120675
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/medicina56120675
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1648-9144/56/12/675
Volltext
Verfasserangaben:Thomas Geyer, Johannes Rübenthaler, Matthias F. Froelich, Laura Sabel, Constantin Marschner, Vincent Schwarze, and Dirk-André Clevert
Beschreibung
Zusammenfassung:Background and objectives: Native ultrasound is the most common imaging modality in obstetrics. The use of contrast-enhanced ultrasound (CEUS) during pregnancy has not been officially approved by leading societies for obstetrics and ultrasound. The present study aims to monitor the safety and diagnostic performance of CEUS for assessing abdominal issues in five pregnant women. Materials and Methods: Five pregnant patients who underwent a total of 11 CEUS examinations between June 2020 and October 2020 were included (mean age: 34 years; mean time of pregnancy: 21 weeks). All CEUS scans were interpreted by one experienced consultant radiologist (EFSUMB Level 3). Results: Upon contrast application, no maternal nor fetal adverse effects were observed. Moreover, no fetal contrast enhancement was observed in any patient. CEUS helped to diagnose renal angiomyolipoma, pyelonephritis, necrotic uterine fibroid, gallbladder polyp, and superior mesenteric vein thrombosis. Conclusions: In our study, off-label use of CEUS showed an excellent safety profile allowing the avoidance of ionizing radiation exposure as well as contrast agents in case of CT or use of gadolinium-based contrast agents in case of MRI. CEUS is a promising diagnostic instrument for facilitating clinical decision-making and improving the management of pregnant women.
Beschreibung:Gesehen am 29.04.2024
Beschreibung:Online Resource
ISSN:1648-9144
DOI:10.3390/medicina56120675